GLP-1
Semaglutide is a synthetic form of the naturally produced hormone GLP-1. The drug is available in injection form and is administered once per week. Semaglutide works by targeting the GLP-1 receptors in the pancreas, brain and stomach. When these receptors are stimulated, they reduce appetite and slow down digestion. As a result, individuals eat less, causing weight loss. Delayed digestion can also have additional benefits, such as improved blood sugar control.
Tirzepatide, is a weekly injectable medication designed to achieve weight loss in patients who struggle with obesity. It’s a compound that imitates two different hormones in the body, GLP-1 and GIP, both of which regulate glucose and insulin levels. The medication is injected subcutaneously in once a week.
Tirzepatide achieves medical weight loss due to its ability to suppress the appetite and regulate blood sugar levels.
Add a footnote if this applies to your business
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.